These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10872343)

  • 21. Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up.
    Bigazzi R; Bianchi S; Buoncristiani E; Campese VM
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):314-9. PubMed ID: 17368007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertension and insulin resistance].
    Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
    Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance and its impact on the approach to therapy of type 2 diabetes.
    Laakso M
    Int J Clin Pract Suppl; 2001 Sep; (121):8-12. PubMed ID: 11594246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension in metabolic syndrome. Etiology and consequences].
    Rett K
    Fortschr Med; 1992 Dec; 110(34):642-4. PubMed ID: 1483616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
    Zarich SW
    Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is insulin resistance atherogenic? A review of the evidence.
    Ferrannini E; Iozzo P
    Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.
    Prior JO; Quiñones MJ; Hernandez-Pampaloni M; Facta AD; Schindler TH; Sayre JW; Hsueh WA; Schelbert HR
    Circulation; 2005 May; 111(18):2291-8. PubMed ID: 15851590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hypertension in patients with diabetes.
    Sowers JR
    Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose metabolism in patients with essential hypertension.
    García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial hypertension and disorders of hydrocarbon metabolism].
    González Maqueda I; Roldán Rabadán I; Armada Romero E; Pereira Bouza J; González Lama I
    Rev Esp Cardiol; 1998; 51 Suppl 4():3-14. PubMed ID: 9883063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the adverse cardiovascular prognosis of type 2 diabetes.
    O'Keefe JH; Miles JM; Harris WH; Moe RM; McCallister BD
    Mayo Clin Proc; 1999 Feb; 74(2):171-80. PubMed ID: 10069357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance exercise training: its role in the prevention of cardiovascular disease.
    Braith RW; Stewart KJ
    Circulation; 2006 Jun; 113(22):2642-50. PubMed ID: 16754812
    [No Abstract]   [Full Text] [Related]  

  • 38. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
    Goldberg RB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The insulin resistance syndrome.
    Smolar EN
    Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.